Catalent
CTLT
#1737
Rank
A$17.34 B
Marketcap
A$95.57
Share price
0.00%
Change (1 day)
10.49%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Last known market cap: A$17.34 Billion

On February 19, 2025 Catalent had a market cap of A$17.34 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025A$17.34 B-6.36%
2024A$18.52 B55.5%
2023A$11.91 B0.08%
2022A$11.90 B-62.34%
2021A$31.61 B41.81%
2020A$22.29 B89.35%
2019A$11.77 B82.65%
2018A$6.44 B-7.81%
2017A$6.99 B49.84%
2016A$4.66 B9.05%
2015A$4.27 B1.44%
2014A$4.21 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Supernus Pharmaceuticals
SUPN
A$3.94 B-77.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$1.13 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
A$15.52 B-10.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
A$1.19 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA